New data obtained has found cases soared over the four weeks to the end of November, with an extra 118 hospitalisations ...
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Weight loss medications Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs.